Short Summary
Minka Lighting and Wangs Alliance settled their IPR dispute over a lighting patent before the trial was instituted. The Board dismissed the petition and treated the settlement agreement as confidential.
Detailed Summary
In IPR2024-01027 concerning U.S. Patent No. 11,028,854 B2, Minka Lighting, LLC and Wangs Alliance Corporation jointly moved to terminate the inter partes review after reaching a settlement that resolved all disputes over the patent. The Patent Trial and Appeal Board, finding good cause given the early stage of the proceeding, dismissed the petition, terminated the case, and ordered the settlement agreement to be kept confidential under 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c). No claim constructions or unpatentability findings were made.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Minka Lighting, LLC vs Wangs Alliance Corporation is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co., Ltd. et al.vsGenghisComm Holdings, LLC
Samsung has filed an IPR petition challenging 16 claims of GenghisComm’s ’568 patent, asserting anticipation and obviousness over multiple prior‑art references and arguing the patent is post‑AIA. The petition seeks institution of the review.
Tesla, Inc.vsGraphite Charging Company LLC
Tesla challenges Graphite Charging Company's patent (8,291,243) in an IPR proceeding, arguing the claims are invalid. The petition asserts grounds of obviousness over prior art references Wang, AESO Report, and Cooley.
Samsung Electronics Co., Ltd. et al.vsHEADWATER RESEARCH LLC
Headwater Research files a response to Samsung’s request for Director Review, defending the PTAB’s discretionary denial of institution and arguing the recission of the Vidal Memo was proper and lawful.
Taiwan Semiconductor Manufacturing Company LimitedvsMarlin Semiconductor Ltd. et al.
The PTAB granted institution for IPR2025-01265, allowing the trial to proceed after determining the petitioner had a reasonable likelihood of prevailing. This notice also details multiple other institutional decisions across various proceedings.
Neurocrine Biosciences, Inc.vsSpruce Biosciences, Inc.
The PTAB held that Neurocrine Biosciences’ challenge to Spruce Biosciences’ ’201 patent succeeded; all 19 claims were found unpatentable for lack of written description under §112(a).
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.